HealthyDirect · GrowthFit for a long SIP
Axis Value Fund
Axis Mutual FundEquity Schemes - Value Fund5.1 years
The schemes seeks to generate consistent long-term capital appreciation by investing predominantly in equity and equity related securities by following value investing strategy.
- NAV
- 20.73
- 29 Oct 2026
- 1Y
- +1.0%
- Trailing CAGR
- Upside capture
- +115%
- Vs NIFTY 500 TRI
- Downside capture
- +87%
- Lower is better
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 100% of rolling 3-year windows.
Fits if · Three-year return is above the category median.
Buy checklist
History depth
Pass
5.1 years of path to read.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
0.87% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -20.2%. Ask whether you can hold through a similar fall.
Vs category
Pass
100% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Pass
Krishnaa Narayan · 2.7 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 33.9% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 20%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+1.0%
- 3Y+17.9%
- 5Y+15.0%
- 10Yn/a
- SI+15.4%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+3.6%
- 3Y+8.5%
- 5Y+15.5%
- 10Yn/a
- Since inception
- +15.4%
- Calendar-day CAGR
- Excess 1Y
- +8.0%
- Category median, same plan and option
- 3Y win rate
- +100%
- Windows beating the median
- 3Y percentile
- 100
- Vs comparable share classes
- SIP 3Y XIRR
- +8.5%
- Simulated monthly SIP
- Worst rolling 3Y
- +16.2%
- 521 daily-ending windows
- Median rolling 3Y
- +23.0%
- Calendar-day CAGR
- Positive rolling 5Y
- +100%
- 22 daily-ending windows
Official benchmark
Date-aligned against NIFTY 500 TRI. Capture ratios use common month-end observations through 30 Oct 2026.
- 1Y excess
- +8.6%
- Fund minus TRI
- 3Y excess
- +7.5%
- Fund minus TRI
- Upside capture
- +115%
- Benchmark-up months
- Downside capture
- +87%
- Lower is better
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -20.2%
- Worst peak-to-trough
- Current
- -5.8%
- Below last peak
- Current spell
- 59 days
- Days below latest peak
- Time below peak
- +84%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 11 days
- 74 recovered episodes
- Longest recovery
- 234 days
- Trough to prior peak
17 Jan 2022 – 30 Nov 2022
Trough 20 Jun 2022 · recovered in 163 days
-20.2%
26 Sept 2024 – 20 Oct 2025
Trough 28 Feb 2025 · recovered in 234 days
-17.1%
2 Jan 2026 – 2 Jul 2026
Trough 30 Mar 2026 · recovered in 94 days
-12.1%
31 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-8.7%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
100
Vs category
100
Consistency
91
Risk-adjusted
58
Drawdown
50
Mean
80
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 100% of rolling 3-year windows.
- Three-year return is above the category median.
- Risk-adjusted return sits above the documented risk-free proxy.
Portfolio
30 Sept 2026 · 88 holdings · top 10 are 33.9%.
- Top 5
- 22.4%
- Top 10
- 33.9%
- Largest holding
- 6.9%
- Effective holdings
- 46.8
Others CBLO
Unspecified
6.9%
ICICI Bank Ltd
Financial
5.3%
HDFC Bank Ltd
Financial
4.5%
Reliance Industries Ltd
Energy & Utilities
3.2%
Welspun Corp Ltd
Materials
2.5%
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Canara Robeco Value Fund
Canara Robeco Mutual Fund
- 1Y
- -8.8%
- 3Y
- +10.1%
- Vol
- 13.9%
- Max DD
- -19.0%
- Sharpe
- 0.50
- 3Y win
- +29%
- Lower volatility
- Shallower drawdown
- Lower TER
Caveat: Lower trailing returns
HSBC Value Fund
HSBC Mutual Fund
- 1Y
- -5.1%
- 3Y
- +14.5%
- Vol
- 15.0%
- Max DD
- -19.6%
- Sharpe
- 0.71
- 3Y win
- +100%
- Shallower drawdown
Caveat: Higher volatility · Higher TER · Lower trailing returns
Mahindra Manulife Value Fund
Mahindra Manulife Mutual Fund
- 1Y
- +0.0%
- 3Y
- n/a
- Vol
- 14.6%
- Max DD
- -11.5%
- Sharpe
- 0.40
- 3Y win
- n/a
- Shallower drawdown
Caveat: Higher volatility · Higher TER · Lower trailing returns